Curis Inc
CRIS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001108205
No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.
Superinvestors holding CRIS, Q2 2026
1 superinvestor reports holding Curis Inc on Form 13F, worth $6.19K in total. Weight is Curis Inc's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Maverick CapitalLee Ainslie | <0.1% | 49,554 | $6.19K | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CRIS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2025
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−92.7%)
Q2 2025
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+7.8%)
Q4 2024
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+8.5%)
Q3 2023
1 superinvestor holding at quarter end
Converted for a 1-for-20 split- Added
- Maverick Capital (+110.2%)
Q2 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (0.0%)
Q1 2023
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−0.3%)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−27.8%)
Q1 2022
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−1.3%)
Q4 2021
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+2.8%)
Q3 2021
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+284.7%)
Q2 2021
1 superinvestor holding at quarter end